Circulating levels of MMP-1, -2, -3, -9, and TIMP-1 are increased in POEMS syndrome.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 11274326.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors quantitatively measured levels of matrix metalloproteinases (MMP), tissue inhibitor of metalloproteinases (TIMP), and vascular endothelial growth factor (VEGF) in blood samples of POEMS syndrome. Circulating levels of MMP-1, -2, -3, -9, and TIMP-1 were more increased in patients with POEMS syndrome than in patients with other neurologic disorders or in healthy controls. Serum levels of VEGF and TIMP-1 were strongly correlated with each other. Increased circulating levels of MMP-1, -2, -3, -9, and TIMP-1 may lead to a better understanding the pathogenesis of POEMS syndrome.
Medical subject headings
- Matrix Metalloproteinase 1
- Matrix Metalloproteinase 2
- Matrix Metalloproteinase 3
- Matrix Metalloproteinase 9
- POEMS Syndrome
- Tissue Inhibitor of Metalloproteinase-1